[
    [
        {
            "time": "2023-04-15",
            "original_text": "复星医药：近期启动新药治疗转移性结直肠癌适应症临床试验",
            "features": {
                "keywords": [
                    "复星医药",
                    "新药",
                    "转移性结直肠癌",
                    "临床试验"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "复星医药：近期启动新药治疗转移性结直肠癌适应症临床试验",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-04-15",
            "original_text": "[推荐评级] 医药行业周报：医药板块涨幅举居前 继续坚持三条主线",
            "features": {
                "keywords": [
                    "医药行业",
                    "周报",
                    "涨幅",
                    "三条主线"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[推荐评级] 医药行业周报：医药板块涨幅举居前 继续坚持三条主线",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-04-15",
            "original_text": "复星医药：控股子公司新药完成临床I期试验",
            "features": {
                "keywords": [
                    "复星医药",
                    "控股子公司",
                    "新药",
                    "临床I期试验"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "复星医药：控股子公司新药完成临床I期试验",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-15",
            "original_text": "市值2500亿股价累计涨90倍 恒瑞医药高估值怎么来的",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "市值",
                    "股价",
                    "高估值"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "市值2500亿股价累计涨90倍 恒瑞医药高估值怎么来的",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-04-15",
            "original_text": "[超配评级] 生物科技行业热点技术专题研究：CAR-T开启中国创新药大幕：生物科技热点技术系列之二-细胞免疫疗法",
            "features": {
                "keywords": [
                    "生物科技",
                    "CAR-T",
                    "创新药",
                    "细胞免疫疗法"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "[超配评级] 生物科技行业热点技术专题研究：CAR-T开启中国创新药大幕：生物科技热点技术系列之二-细胞免疫疗法",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]